Induction of p53 and increased sensitivity to cisplatin in ataxia-telangiectasia cells

Oncogene. 1996 Aug 1;13(3):655-9.

Abstract

Several reports have demonstrated a defective p53 response to ionizing radiation exposure in ataxia-telangiectasia (A-T) cells. On the other hand, p53 induction was normal after u.v. irradiation, an agent to which A-T cells are not hypersensitive. We show here that A-T cells are more sensitive than normal lymphoblastoid cells to cisplatin treatment but the rate of induction of p53 by cisplatin is similar in both cell types. In addition, the half-life of p53, both in the induced and uninduced forms, is the same in A-T and normal lymphoblastoid cells. The use of a reporter assay to determine the functional status of p53 confirmed the results obtained in the induction experiments with cisplatin. These results demonstrate that p53 induction status in A-T cells does not correlate with sensitivity to the inducting agent and there is no inherent defect in the turn-over of p53 in the induced or uninduced states in A-T.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Ataxia Telangiectasia / drug therapy*
  • Ataxia Telangiectasia / metabolism*
  • Ataxia Telangiectasia / pathology
  • Cisplatin / pharmacology*
  • DNA Damage
  • Lymphocytes / metabolism
  • Lymphocytes / pathology
  • Lymphocytes / radiation effects
  • Tumor Suppressor Protein p53 / biosynthesis*
  • Tumor Suppressor Protein p53 / physiology

Substances

  • Antineoplastic Agents
  • Tumor Suppressor Protein p53
  • Cisplatin